Category:
The pandemic has upended communications pathways, preferences, and practices for healthcare providers (HCPs). Standing expectations and approaches for communicating with peers, pharma representatives, and patients have been disrupted. Probably permanently. This forced sea change is being played out against significant background changes in the population of HCPs, their terms of employment, and lifestyle expectations. Digital […]
The race to develop a COVID-19 vaccine is complicated and challenging. The media is filled with wishful thinking, random prognosticators and a healthy dose of hype. A handful of efforts are entering Phase 3 clinical trials to test different vaccines. As developments occur, consider these six factors in evaluating the news. Developers. Some of the […]
COVID-19 has been an incredible digital accelerator. Now every brand and every company, in the absence of in-person detailing and live congresses, is rushing to exploit digital and social non personal promotion (NPP). Brands are creating multi-stage email campaigns, MoA and KOL videos, social media posts and ads, display and retargeted digital ads, webinars, and […]
While COVID-19 has captured the attention of the world, it hasn’t closed down exploration and development of new drugs and new therapies. In many sectors of the healthcare and biopharma universe, innovative thinking and new clinical approaches by entrepreneurial companies are competing to bring exciting and effective new products to market. LiveWorld studied several of […]
This article was previously published in PM360 on April 15, 2020. This is part 3 of 3 in the article series: Thinking More Digitally in the Age of Coronavirus “As hospitals struggle with a surge of coronavirus infection patients, a second crisis is brewing in physicians’ offices… steep drop-offs in visits as patients stay away, fearful […]
This is Part 2 of 3 in a series: Thinking More Digitally in the Age of Coronavirus The tried and true formula of sustained face to face relationships between HCPs and pharma reps is becoming a thing of the past: The steady decline of rep access coupled with the Covid-19 pandemic, focus our thinking on the […]
This article was previously published in PM360 on March 26, 2020. This is Part 1 of 3 in a series: Thinking More Digitally in the Age of Coronavirus On Friday the 13th, Medscape reported that 26 medical conferences were being cancelled or postponed. Reactions from commenters were mixed, from “remember the Biogen folks,” to “I don’t […]
Liveworld
post by: Danny Flamberg, VP Strategy- HCP